ELVN

ELVN Operating Cash Flow (Statement)

-$66.94MTTM · USD

Period ending:

ELVN FY Cash from OperationsUSD
ELVN FY Cash from Operations2017-12-31: -$8.79M2018-12-31: -$8.78M2019-12-31: -$21.88M2020-12-31: -$8.53M2021-12-31: -$19.13M2022-12-31: -$32.08M2023-12-31: -$61.27M2024-12-31: -$73.19M2025-12-31: -$70.30M$0.00-$73.19M
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ELVN operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Enliven Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-70,301,000
-73,192,000
-61,269,000
-32,077,000
-19,134,000
-8,529,000
-21,877,000
-8,777,000
-8,785,000

Compare operating cash flow (statement)

All ELVN financial metrics · ELVN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.